Results 31 to 40 of about 2,789 (159)

Manifestations of somatic disturbances in early postmenopause in women after physiological and surgical menopause [PDF]

Vojnosanitetski Pregled, 2006
Background/Aim. The most common secondary manifestations of menopause are clinical manifestations of estrogen deficiency. They could be early and late. The aim of this study was to compare manifestations of somatic disturbances in early postmenopause in ...
Ninčić Dejan, Žikić Dragan, Ivković-Kapicl Tatjana, Mastilović Katarina   +3 more
doaj   +1 more source

Differentiated approach to the treatment of genitourinary syndrome in perimenopausal women

Репродуктивная эндокринология, 2019
Objective. To compare the clinical efficacy of monotherapy with menopausal hormonal therapy (climonorm) in the treatment of genitourinary syndrome of menopause with the effectiveness of monotherapy by M-anticholinergic mirabegron (betmiga) and a ...
Ю. П. Вдовиченко, О. О. Єфіменко, Н. Ю. Педаченко, О. І. Яцина   +3 more
doaj   +1 more source

The role of vitamin D in menopausal women’s health

Frontiers in Physiology, 2023
Vitamin D (VD) is known to play an important role in the maintenance of calcium homeostasis and bone metabolism. In recent years, there has also been a growing interest in Vitamin D for health issues beyond the bones.
Zhaojun Mei, Hong Hu, Yi Zou, Dandan Li
doaj   +1 more source

Hormone therapy for genitourinary syndrome of menopause: reality and prospects

Клинический разбор в общей медицине
Genitourinary syndrome of menopause still represents one of the most pressing unresolved issues of modern gynecology. High prevalence and the data suggesting a marked decline in the quality of life in general and sexual life in particular in patients of ...
Mekan R. Orazov, Viktor E. Radzinsky, Evgeny D. Dolgov   +2 more
doaj   +1 more source

Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases

Sexual Medicine, 2016
Introduction: Ospemifene (Osphena, Shionogi Inc, Florham, NJ, USA) is an estrogen agonist and antagonist approved by the U.S. Federal Drug Administration for the treatment of “moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due ...
Andrew T. Goldstein, MD, Michelle A. King, MSC   +1 more
doaj   +1 more source

Risk Factors Associated With the Number of Symptoms and Distress Caused by Genitourinary Syndrome of Menopause in Taiwanese Women

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT A high percentage of women who undergo the transition to postmenopause experience both menopausal symptoms and genitourinary syndrome of menopause (GSM). However, GSM is often underdiagnosed. This research aims to identify risk factors that may influence the number of GSM symptoms and whether they cause distress in Taiwanese women > 45 years ...
Shu‐Fang Su, Chiu‐Lin Wang, Shu‐Yuan Lin   +2 more
wiley   +1 more source

Genitourinary Syndrome of Menopause.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2022
Valadares, Ana Lúcia Ribeiro, Kulak Junior, Jaime, Paiva, Lúcia Helena Simões Da Costa, Nasser, Elizabeth Jeha, Silva, Célia Regina Da, Nahas, Eliana Aguiar Petri, Baccaro, Luiz Francisco Cintra, Rodrigues, Márcio Alexandre Hipólito, Albernaz, Marco Aurélio, Wender, Maria Celeste Osório, Mendes, Maria Célia, Dardes, Rita De Cassia De Maio, Strufaldi, Rodolfo, Bocardo, Rogerio Cesar, Pompei, Luciano De Melo   +14 more
  +8 more sources

When Intimacy Hurts: Dyspareunia in Genitourinary Syndrome of Menopause - A Review of Treatment Options

Quality in Sport
Dyspareunia, defined as pain during or immediately after sexual intercourse, is one of the most common and troublesome symptoms of Genitourinary syndrome of menopause (GSM), affecting a significant number of perimenopausal and postmenopausal women. This
Julia Dąbrowska, Michał Białogłowski, Katarzyna Mazurek, Anna Gęborys, Maja Wojcieszak, Julia Matuszewska, Weronika Woźnica, Alicja Maziarczyk, Jakub Lambach, Dominika Miazga   +9 more
doaj   +1 more source

Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study

BMC Women's Health, 2021
Objective To study knowledge regarding genitourinary syndrome of menopause (GSM) and the treatments for it and to analyze treatment adherence during the COVID-19 confinement.
Laura Baquedano Mainar, Sonia Sánchez Méndez, Peña Dieste Pérez, Mónica Hernández Aragón, Nicolás Mendoza Ladrón de Guevara, the COMEM Study Spanish investigators   +5 more
doaj   +1 more source

The Role of Vaginal Oestrogen Therapy in Postmenopausal Women With Pelvic Organ Prolapse: Does It Have Any Impact on Perioperative Outcomes? A Systematic Review of Randomised Controlled Trials

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Pelvic organ prolapse (POP) affects up to 50% of postmenopausal women, negatively impacting sexual function and quality of life. While surgery remains the primary treatment, increasing attention has been given to perioperative vaginal oestrogen therapy and its potential impact on surgical outcomes.
Gilda Sicilia, Salvatore Giovanni Vitale, Maurizio Nicola D'Alterio, Stefania Saponara, Francesco Scicchitano, Anna Maria Fulghesu, Rossella E. Nappi, Stefano Angioni   +7 more
wiley   +1 more source